Loading companies…
Loading companies…
United Kingdom · Biotech · Healthtech · Enterprise software
Develops proprietary eye-drop matrix technology for ocular surface diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | £2M | Cure EB — Role not disclosedDEBRA Research — Role not disclosedEmpirical Ventures — Role not disclosedOshen Bio — Role not disclosedSFC Capital — Role not disclosed |